Bristol-Myers Squibb Co (BMY) CEO Giovanni Caforio on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/04/22
ADDING and REPLACING Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021Business Wire • 02/04/22
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should KnowZacks Investment Research • 01/29/22
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3BBusiness Wire • 01/28/22
Bristol Myers Squibb Looks Strong In 2022, Century Deal Can Help Establish Cell Therapy LeadershipSeeking Alpha • 01/17/22